Industry-Supported Symposia
The following Industry-Supported Symposia are organized by sponsors of ICNMD 2024. More Details will be provided in the next few months.
- ISS01
- Title: Treatment Approaches for Pre-Symptomatic Infants Living with SMA
- Time: 13:00 – 14:00
- Room: Riverview Room 5
- Topic: SMA
- ISS02
- Title: To the Joy of Options - Exploring Targeted Treatment Approaches in gMG
- Time: 13:00 – 14:00
- Room: M1
- Topic: MG
- ISS03
- Title: Immunoglobulin Therapies in Practice: Overcoming Challenges Along the CIDP Patient Journey
- Time: 13:00 – 14:00
- Room: Riverview Room 4
- Topic: CIDP
- ISS04
- Title: Advancing Neurodegenerative Research: Mechanisms, Biomarkers & Treatment Challenges
- Time: 07:00 – 08:00
- Room: M1
- Topic: SMA
- ISS05
- Title: Breaking New Ground In The Treatment Of Guillain-Barré Syndrome
- Time: 07:00 – 08:00
- Room: M8
- Topic: TBA
- ISS06
- Title: Spotlight on nmDMD: Exploring a Targeted Treatment Option
- Time: 13:00 – 14:00
- Room: Riverview Room 4
- Topic: DMD
- ISS07
- Title: Treating Myasthenia Gravis by Targeting FcRn: Clinical Data and Perspectives From Global Experts
- Time: 13:00 – 14:00
- Room: Riverview Room 5
- Topic: MG
- ISS08
- Title: Reimagining SMA Care with Newborn Screening and Gene Therapy
- Time: 13:00 – 14:00
- Room: M1
- Topic: SMA
- ISS09
- Title: Advancements in CIDP: The Patient Experience and Clinical Updates from Recent Argenx Trials
- Time: 13:00 – 14:00
- Room: Riverview Room 4
- Topic: CIDP
- ISS10
- Title: Preparing for A Future with Gene Therapy in DMD: A Journey Towards Inclusion and Equity
- Time: 13:00 – 14:00
- Room: Riverview Room 5
- Topic: DMD
- Time: 13:00 – 14:00
- Topic: FSHD
- ISS11
- Title: Navigating the Disease Journey: Pathophysiology and Progression of LGMDs
- Time: 13:00 – 14:00
- Room: Riverview Room 5
- Topic: LGMD
- ISS12
- Title: Treatment of Generalized Myasthenia Gravis (gMG)
- Time: 13:00 – 14:00
- Room: Riverview Room 4
- Topic: MG